BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36898947)

  • 101. Regionalization of Testis Cancer Care-Is It Necessary?
    Heidenreich A; Paffenholz P; Pfister D
    Urol Clin North Am; 2024 Aug; 51(3):421-427. PubMed ID: 38925744
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's Oncology Group.
    Singla N; Wong J; Singla S; Krailo M; Huang L; Shaikh F; Billmire D; Rescorla F; Ross J; Dicken B; Amatruda JF; Lindsay Frazier A; Bagrodia A
    J Pediatr Urol; 2022 Aug; 18(4):505-511. PubMed ID: 35606324
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The Importance of Repeat Imaging Prior to Treatment Decision-making in Testicular Cancer: Commentary From the Inaugural Global Society of Rare Genitourinary Tumors Summit.
    McAlpine K; Clark R; Spiess PE; Necchi A; Gage K; Hamilton RJ
    Clin Genitourin Cancer; 2023 Jun; 21(3):418.e1-418.e6. PubMed ID: 36624008
    [TBL] [Abstract][Full Text] [Related]  

  • 104. SEOM clinical guidelines for the management of germ cell testicular cancer (2016).
    Aparicio J; Terrasa J; Durán I; Germà-Lluch JR; Gironés R; González-Billalabeitia E; Gumà J; Maroto P; Pinto A; García-Del-Muro X
    Clin Transl Oncol; 2016 Dec; 18(12):1187-1196. PubMed ID: 27815687
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Testicular cancer: a prototypic tumor of young adults.
    Hayes-Lattin B; Nichols CR
    Semin Oncol; 2009 Oct; 36(5):432-8. PubMed ID: 19835738
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Cellular senescence in testicular cancer. Is there a correlation with the preoperative markers and the extent of the tumor? An experimental study.
    Tatanis V; Veroutis D; Pantelis P; Theocharous G; Sarlanis H; Georgiou A; Peteinaris A; Natsos A; Moulavasilis N; Kavantzas N; Kotsinas A; Adamakis I
    Arch Ital Urol Androl; 2024 Mar; 96(1):12246. PubMed ID: 38441175
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Adherence Outcomes and Risk Factors Predicting Nonadherence to Active Surveillance in Patients With Stage 1 Testicular Germ Cell Tumors.
    Liang R; Adams D; Roncolato F; Asghari R; Descallar J; Pal A; Chua W; Balakrishnar B
    Clin Genitourin Cancer; 2024 Aug; 22(4):102116. PubMed ID: 38810324
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Clinicopathologic features and proposed grossing protocol of orchiectomy specimens performed for gender affirmation surgery.
    Cornejo KM; Oliva E; Crotty R; Sadow PM; Devins K; Wintner A; Wu CL
    Hum Pathol; 2022 Sep; 127():21-27. PubMed ID: 35660072
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors.
    Stoneham SJ; Hale JP; Rodriguez-Galindo C; Dang H; Olson T; Murray M; Amatruda JF; Thornton C; Arul GS; Billmire D; Krailo M; Stark D; Covens A; Hurteau J; Stenning S; Nicholson JC; Gershenson D; Frazier AL
    Oncologist; 2014 Jul; 19(7):689-92. PubMed ID: 24899644
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Active surveillance: minimising treatment while maximising outcomes in testis cancer.
    Conduit C; Tran B
    Transl Androl Urol; 2023 Sep; 12(9):1371-1374. PubMed ID: 37814695
    [No Abstract]   [Full Text] [Related]  

  • 111. Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.
    Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; Antunes L; Jerónimo C; Henrique R
    Hum Pathol; 2018 Dec; 82():113-124. PubMed ID: 30041024
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Testicular Cancer: Contemporary Updates in Staging.
    Al-Obaidy KI; Magers MJ; Idrees MT
    Surg Pathol Clin; 2022 Dec; 15(4):745-757. PubMed ID: 36344187
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Reprint of: Updates in 2022 on the staging of testicular germ cell tumors.
    Canete Portillo S; Rais-Bahrami S; Magi-Galluzzi C
    Hum Pathol; 2023 Mar; 133():153-161. PubMed ID: 36898947
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Updates in 2022 on the staging of testicular germ cell tumors.
    Canete Portillo S; Rais-Bahrami S; Magi-Galluzzi C
    Hum Pathol; 2022 Oct; 128():152-160. PubMed ID: 35926809
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The Significance of Spermatic Cord Involvement by Testicular Germ Cell Tumors: Should We Be Staging Discontinuous Invasion From Involved Lymphovascular Spaces Differently From Direct Extension?
    Sanfrancesco JM; Trevino KE; Xu H; Ulbright TM; Idrees MT
    Am J Surg Pathol; 2018 Mar; 42(3):306-311. PubMed ID: 29309304
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?
    Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
    Mod Pathol; 2021 Apr; 34(4):834-841. PubMed ID: 33319858
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.